A successful search for new, efficient, and silver-free manufacturing processes for key platinum( ii ) intermediates applied in antibody–drug conjugate (ADC) production | Synapse

⌘+K

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast CancerLate-Phase Clinical Trial · 2014 · 545 citations
2Recent Developments in ADC Technology: Preclinical Studies Signal Future Clinical TrendsOriginal Research · 2017 · 101 citations
3Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugatesOriginal Research · 2012 · 137 citations
4Contribution of Linker Stability to the Activities of Anticancer ImmunoconjugatesOriginal Research · 2008 · 481 citations
5Platinum(II) as Bifunctional Linker in Antibody–Drug Conjugate Formation: Coupling of a 4‐Nitrobenzo‐2‐oxa‐1,3‐diazole Fluorophore to Trastuzumab as a ModelOriginal Research · 2015 · 22 citations
6A Novel Platinum(II)–Based Bifunctional ADC Linker Benchmarked Using 89Zr-Desferal and Auristatin F–Conjugated TrastuzumabOriginal Research · 2016 · 38 citations
7In Vivo Characterization of Platinum(II)-Based Linker Technology for the Development of Antibody–Drug Conjugates: Taking Advantage of Dual Labeling with 195mPt and 89ZrOriginal Research · 2018 · 23 citations
8First platinum(II)-based metal-organic linker technology (Lx®) for a plug-and-play development of antibody-drug conjugates (ADCs)Original Research · 2019 · 21 citations
9Waste-wood-derived sustainable N and S co-doped hard carbon for enhanced sodium-ion storageGreen Chemistry · 2026
10Biobased antifatigue organohydrogel with superior ionic conductivity enabled by lignin nanostructuresGreen Chemistry · 2026

More from Green Chemistry

More from Amsterdam UMC Location Vrije Universiteit Amsterdam